Literature DB >> 15537449

Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide.

Thorsten Schinke1, Sarah Liese, Matthias Priemel, Michael Haberland, Arndt F Schilling, Philip Catala-Lehnen, Dagmar Blicharski, Johannes M Rueger, Robert F Gagel, Ronald B Emeson, Michael Amling.   

Abstract

UNLABELLED: We recently described an unexpected high bone mass phenotype in mice lacking the Calca gene that encodes CT and alphaCGRP. Here we show that mice specifically lacking alphaCGRP expression display an osteopenia caused by a decreased bone formation. These results show that alphaCGRP is a physiological activator of bone formation and that the high bone mass phenotype of the Calca-deficient mice is caused by the absence of CT.
INTRODUCTION: Calcitonin (CT) and alpha-calcitonin gene-related peptide (alphaCGRP) are two polypeptides without completely defined physiologic functions that are both derived from the Calca gene by alternative splicing. We have recently described an unexpected high bone mass phenotype in mice carrying a targeted deletion of the Calca gene. To uncover whether this phenotype is caused by the absence of CT or by the absence of alphaCGRP, we analyzed a mouse model, where the production of alphaCGRP is selectively abolished.
MATERIALS AND METHODS: Bones from Calca(-/-) mice, alphaCGRP(-/-) mice, and their corresponding wildtype controls were analyzed using radiography, muCT imaging, and undecalcified histology. Cellular activities were assessed using dynamic histomorphometry and by measuring the urinary collagen degradation products. CT expression was determined using radioimmunoassay and RT-PCR. Immunohistochemistry was performed using an anti-CGRP antibody on decalcified bone sections.
RESULTS: Unlike the Calca-deficient mice, the alphaCGRP-deficient mice do not display a high bone mass phenotype. In contrast, they develop an osteopenia that is caused by a reduced bone formation rate. Serum levels and thyroid expression of CT are not elevated in alphaCGRP-deficient mice. While CGRP expression is detectable in neuronal cell close to trabecular bone structures, the components of the CGRP receptor are expressed in differentiated osteoblast cultures.
CONCLUSION: The discrepancy between the bone phenotypes of Calca(-/-) mice and alphaCGRP(-/-) mice show that the high bone mass phenotype of the Calca(-/-) mice is caused by the absence of CT. The osteopenia observed in the alphaCGRP(-/-) mice that have normal levels of CT further show that alphaCGRP is a physiologic activator of bone formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537449     DOI: 10.1359/JBMR.040915

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  46 in total

Review 1.  Evolving concepts in neurogenic osteoporosis.

Authors:  Weiping Qin; William A Bauman; Christopher P Cardozo
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

Review 2.  Regulation of bone remodeling by the central and peripheral nervous system.

Authors:  Florent Elefteriou
Journal:  Arch Biochem Biophys       Date:  2008-03-23       Impact factor: 4.013

3.  CGRP gene-modified rBMSCs show better osteogenic differentiation capacity in vitro.

Authors:  Xijiao Yu; Shuang Liu; Hui Chen; Xinyu Zhao; Xue Chen; Yi Du; Shu Li
Journal:  J Mol Histol       Date:  2018-05-30       Impact factor: 2.611

4.  Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes.

Authors:  Jillian N Collins; Beth J Kirby; Janine P Woodrow; Robert F Gagel; Clifford J Rosen; Natalie A Sims; Christopher S Kovacs
Journal:  Endocrinology       Date:  2013-03-05       Impact factor: 4.736

5.  Balanced translocation in a patient with craniosynostosis disrupts the SOX6 gene and an evolutionarily conserved non-transcribed region.

Authors:  A Tagariello; R Heller; A Greven; V M Kalscheuer; T Molter; A Rauch; W Kress; A Winterpacht
Journal:  J Med Genet       Date:  2005-10-28       Impact factor: 6.318

6.  Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.

Authors:  Liping Wang; Xiaoyou Shi; Rong Zhao; Bernard P Halloran; David J Clark; Christopher R Jacobs; Wade S Kingery
Journal:  Bone       Date:  2009-12-02       Impact factor: 4.398

7.  The influence of the sensory neurotransmitter calcitonin gene-related peptide on bone marrow mesenchymal stem cells from ovariectomized rats.

Authors:  Jie Chen; Ge Ma; Wei Liu; Yanpu Liu; Yuxiang Ding
Journal:  J Bone Miner Metab       Date:  2016-09-13       Impact factor: 2.626

8.  Alpha-calcitonin gene-related peptide can reverse the catabolic influence of UHMWPE particles on RANKL expression in primary human osteoblasts.

Authors:  Max D Kauther; Jie Xu; Christian Wedemeyer
Journal:  Int J Biol Sci       Date:  2010-09-15       Impact factor: 6.580

9.  Effects of alpha-calcitonin gene-related peptide on osteoprotegerin and receptor activator of nuclear factor-κB ligand expression in MG-63 osteoblast-like cells exposed to polyethylene particles.

Authors:  Jie Xu; Max D Kauther; Julia Hartl; Christian Wedemeyer
Journal:  J Orthop Surg Res       Date:  2010-11-04       Impact factor: 2.359

10.  Calcitonin gene-related peptide stimulates BMP-2 expression and the differentiation of human osteoblast-like cells in vitro.

Authors:  Gang Tian; Gang Zhang; Ying-hui Tan
Journal:  Acta Pharmacol Sin       Date:  2013-05-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.